Doptelet

Product manufactured by Akarx, Inc.

Application Nr Approved Date Route Status External Links
NDA210238 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Doptelet Is A Thrombopoietin Receptor Agonist Indicated For The Treatment Of: Thrombocytopenia In Adult Patients With Chronic Liver Disease Who Are Scheduled To Undergo A Procedure. ( 1.1 ) Thrombocytopenia In Adult Patients With Chronic Immune Thrombocytopenia Who Have Had An Insufficient Response To A Previous Treatment. ( 1.2 ) 1.1 Treatment Of Thrombocytopenia In Patients With Chronic Liver Disease (Cld) Doptelet Is Indicated For The Treatment Of Thrombocytopenia In Adult Patients With Chronic Liver Disease Who Are Scheduled To Undergo A Procedure. 1.2 Treatment Of Thrombocytopenia In Patients With Chronic Immune Thrombocytopenia (Itp) Doptelet Is Indicated For The Treatment Of Thrombocytopenia In Adult Patients With Chronic Immune Thrombocytopenia Who Have Had An Insufficient Response To A Previous Treatment.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Avatrombopag Maleate AVATROMBOPAG MALEATE ZINC12358683

Comments